Optimized Synthesis Route for Iloperidone Intermediate CAS 58113-30-7
Global demand for antipsychotic medications continues to drive the need for reliable API supply chains. Procurement teams and R&D directors prioritize consistency in Pharmaceutical Intermediate quality to ensure downstream synthesis success. As a leading Global Manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. delivers stable supply solutions for critical compounds like 1-[4-(3-Chloropropoxy)-3-Methoxyphenyl]Ethanone. Supply chain volatility requires partners who can guarantee continuous production capacity without compromising on analytical verification.
Technical specifications and analytical methods
Ensuring High Purity requires rigorous analytical verification. Below are the standard specifications for 4-(3-Chloropropoxy)-3-Methoxyacetophenone, a key Iloperidone Intermediate used in modern psychiatric drug manufacturing.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 58113-30-7 | N/A |
| Chemical Name | 1-[4-(3-Chloropropoxy)-3-Methoxyphenyl]Ethanone | N/A |
| Purity | >99.0% | HPLC / UPLC |
| Appearance | White to Off-White Solid | Visual |
| Documentation | Full COA Provided | QC Department |
Our Industrial Purity standards exceed typical market expectations, supported by comprehensive COA documentation for every batch.
Troubleshooting common impurities and yield issues
Optimizing the Manufacturing Process is critical for minimizing waste and maximizing output. Process chemists often encounter specific challenges during alkylation steps that affect overall efficiency.
Minimizing Dimer Impurity Formation
Traditional methods often suffer from dimerization when reaction times are extended or solvent systems are suboptimal. Utilizing phase transfer catalysts and controlled temperature profiles significantly reduces unwanted byproducts, ensuring the final API Intermediate meets strict regulatory limits.
Optimizing Solvent and Base Systems
Selection of acetonitrile over acetone, combined with potassium carbonate, improves conversion rates. This adjustment prevents the degradation associated with high vacuum distillation, preserving yield and reducing operational complexity.
One-Pot Synthesis Efficiency
Reducing isolation steps improves the Synthesis Route by eliminating work-up procedures between stages. Direct use of the reaction mixture for subsequent alkylation minimizes material loss and accelerates production timelines.
Factory-direct bulk pricing advantages and supply chain stability
Direct manufacturing allows for competitive Bulk Price structures that benefit large-scale production runs. NINGBO INNO PHARMCHEM CO.,LTD. ensures raw material security and consistent output regardless of market fluctuations. Procurement officers can rely on long-term contracts that stabilize costs and secure inventory levels for critical Pharmaceutical Intermediate needs.
Secure your pipeline with verified quality and reliable delivery schedules.
Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.